Dr. Cheung Sai Yin - Pathology
Specialist in Pathology
Highlights
- MCHK RegisteredVerified
- 1 LocationsKowloon Tong
- Specialist in PathologyBachelor of Medicine and Bachelor of Surgery (MBChB) · Fellow of the Hong Kong College of Pathologists · Fellow of the Hong Kong Academy of Medicine (Pathology) · Medical degree 2005
- InsuranceBeing compiled｜See details
About
Dr. Cheung Sai Yin practises Pathology in Kowloon Tong, Hong Kong.
Education
Specialist in Pathology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)2005
- Fellow of the Hong Kong Academy of Medicine (Pathology)Fellow of the Hong Kong Academy of Medicine (Pathology)
- Specialist in Pathology
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Locations
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Cheung Sai Yin? Claim page and update insurance →
FAQ
Is Dr. Cheung Sai Yin any good?
Dr. Cheung Sai Yin practises Pathology in Kowloon Tong, Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Cheung Sai Yin do?
Dr. Cheung Sai Yin practises in Pathology.
Where does Dr. Cheung Sai Yin practise?
Dr. Cheung Sai Yin practises at Hong Kong Baptist Hospital.
Are you Dr. Cheung Sai Yin? Claim this page to update and manage.
ClaimResearch and publications
17 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.Pathology · 2021
- Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors.Breast cancer research and treatment · 2020
- Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer.Histopathology · 2020
- The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.The oncologist · 2020
- Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers.Cancer immunology, immunotherapy : CII · 2020
- Improved Prognostication for the Updated AJCC Breast Cancer Pathological Prognostic Staging Varied in Higher-Stage Groups.Clinical breast cancer · 2020
- Predicting Outcome in Mammary Phyllodes Tumors: Relevance of Clinicopathological Features.Annals of surgical oncology · 2019
- GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer.Breast cancer research and treatment · 2018
- Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.Scientific reports · 2018
- CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer.Journal of clinical pathology · 2018
- Amyloid Precursor Protein Is Associated with Aggressive Behavior in Nonluminal Breast Cancers.The oncologist · 2018
- Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.The oncologist · 2017
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer